Aspirin hydrolysis in human and experimental animal plasma and the effect of metal cations on hydrolase activities

Drug Metabolism and Disposition

Volumn 41, Issue 7, 2013, Pages 1450-1456

  Bahar, Fatma Goksin ^a   Imai, Teruko ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ARYLDIALKYLPHOSPHATASE; CALCIUM; CARBOXYLESTERASE; CHOLINESTERASE; HYDROLASE; MAGNESIUM; PROFENAMINE; ZINC;

ADULT; ARTICLE; CONTROLLED STUDY; DOG; DRUG COMPETITION; DRUG HYDROLYSIS; ENZYME ACTIVITY; ENZYME BINDING; ENZYME CONFORMATION; ENZYME INHIBITION; HAPLORHINI; HUMAN; MALE; MINIPIG; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT;

ADULT; ANIMALS; ARYLDIALKYLPHOSPHATASE; ASPIRIN; BUTYRYLCHOLINESTERASE; CALCIUM; CATIONS, DIVALENT; DOGS; HUMANS; HYDROLASES; HYDROLYSIS; MAGNESIUM; MALE; MICE; PHENOTHIAZINES; RABBITS; RATS; RATS, WISTAR; ZINC;

ANIMALIA; CANIS FAMILIARIS; ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 84879091376     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.113.051805     Document Type: Article

References (44)

1. Bahar FG, Ohura K, Ogihara T, and Imai T (2012) Species difference of esterase expression and hydrolase activity in plasma. J Pharm Sci 101:3979-3988.
2. Bayliss BJ and Todrick A (1956) The use of a selective acetylcholinesterase inhibitor in the estimation of pseudocholinesterase activity in rat brain. Biochem J 62:62-67.
3. Berry LM, Wollenberg L, and Zhao Z (2009) Esterase activities in the blood, liver and intestine of several preclinical species and humans. Drug Metab Lett 3:70-77.
4. Block W and Arndt R (1978) Chromatographic study on the specificity of bis-pnitrophenylphosphate in vivo. Identification of labelled proteins of rat liver after intravenous injection of bis-p-nitro[14C]phenylphosphate as carboxylesterases and amidases. Biochim Biophys Acta 524:85-93.
5. Chuang VT and Otagiri M (2006) Stereoselective binding of human serum albumin. Chirality 18: 159-166.
6. Coku-graş AN, Cengiz D, and Tezcan EF (2003) The effects of Ni2+, Co2+, and Mn2+ on human serum butyrylcholinesterase. J Protein Chem 22:585-589.
7. Halushka MK and Halushka PV (2002) Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2? Circulation 105:1620-1622.
8. Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R, Dvir H, Ravelli RBG, McCarthy A, and Toker L, et al. (2004) Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol 11: 412-419.
9. Heymann E and Mentlein R (1988) Identification, localization and specificity of detoxifying hydrolases in rat tissues, in Metabolism of Xenobiotics (Gorrod JW, Oelschlager H, and Caldwell J, eds, ed) pp 189-197, Taylor and Francis Publications, London.
10. Hofstee BHJ (1951) Spectrophotometric determinations of esterases. Science 114:128-130.
11. Imai T (2006) Human carboxylesterase isozymes: Catalytic properties and rational drug design. Drug Metab Pharmacokinet 21:173-185.
12. Imai T, Taketani M, Shii M, Hosokawa M, and Chiba K (2006) Substrate specificity of carboxylesterase isozymes and their contribution to hydrolase activity in human liver and small intestine. Drug Metab Dispos 34:1734-1741.
13. Inoue M, Morikawa M, Tsuboi M, Ito Y, and Sugiura M (1980) Comparative study of human intestinal and hepatic esterases as related to enzymatic properties and hydrolizing activity for ester-type drugs. Jpn J Pharmacol 30:529-535.
14. Jaichander P, Selvarajan K, Garelnabi M, and Parthasarathy S (2008) Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin. J Lipid Res 49:2142-2148.
15. Josse D, Lockridge O, Xie W, Bartels CF, Schopfer LM, and Masson P (2001) The active site of human paraoxonase (PON1). J Appl Toxicol 21 (Suppl 1):S7-S11.
16. Khersonsky O and Tawfik DS (2006) The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases. J Biol Chem 281:7649-7656.
17. Kretsinger RH (1976) Calcium-binding proteins. Annu Rev Biochem 45:239-266.
18. Kuo CL and La Du BN (1995) Comparison of purified human and rabbit serum paraoxonases. Drug Metab Dispos 23:935-944.
19. Kuo CL and La Du BN (1998) Calcium binding by human and rabbit serum paraoxonases. Structural stability and enzymatic activity. Drug Metab Dispos 26:653-660.
20. Li B, Sedlacek M, Manoharan I, Boopathy R, Duysen EG, Masson P, and Lockridge O (2005) Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma. Biochem Pharmacol 70:1673-1684.
21. Li H, Schopfer LM, Masson P, and Lockridge O (2008) Lamellipodin proline rich peptides associated with native plasma butyrylcholinesterase tetramers. Biochem J 411:425-432.
22. Liederer BM and Borchardt RT (2006) Enzymes involved in the bioconversion of ester-based prodrugs. J Pharm Sci 95:1177-1195.
23. Liyasova MS, Schopfer LM, and Lockridge O (2010) Reaction of human albumin with aspirin in vitro: Mass spectrometric identification of acetylated lysines 199, 402, 519, and 545. Biochem Pharmacol 79:784-791.
24. Lockridge O and Quinn DM (2010) Esterases, in Comprehensive Toxicology (McQueen CA ed) 2nd edn, pp 2432273, Elsevier Ltd, Kidlington, UK
25. Lockridge O, Bartels CF, Vaughan TA, Wong CK, Norton SE, and Johnson LL (1987) Complete amino acid sequence of human serum cholinesterase. J Biol Chem 262:549-557.
26. Lockridge O, Xue W, Gaydess A, Grigoryan H, Ding SJ, Schopfer LM, Hinrichs SH, and Masson P (2008) Pseudo-esterase activity of human albumin: Slow turnover on tyrosine 411 and stable acetylation of 82 residues including 59 lysines. J Biol Chem 283:22582-22590.
27. Marquis JK (1983) Aluminum inhibition of human serum cholinesterase. Bull Environ Contam Toxicol 31:164-169.
28. Masson P, Froment MT, Fortier PL, Visicchio JE, Bartels CF, and Lockridge O (1998) Butyrylcholinesterase-catalysed hydrolysis of aspirin, a negatively charged ester, and aspirinrelated neutral esters. Biochim Biophys Acta 1387:41-52.
29. Morgan AM and Truitt EB, Jr (1965) Evaluation of acetylsalicylic acid esterase in aspirin metabolism. Interspecies comparison. J Pharm Sci 54:1640-1646.
30. Morikawa M, Inoue M, Tsuboi M, and Sugiura M (1979) Studies on aspirin esterase of human serum. Jpn J Pharmacol 29:581-586.
31. Nicolet Y, Lockridge O, Masson P, Fontecilla-Camps JC, and Nachon F (2003) Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. J Biol Chem 278:41141-41147.
32. Rowland M, Riegelman S, Harris PA, and Sholkoff SD (1972) Absorption kinetics of aspirin in man following oral administration of an aqueous solution. J Pharm Sci 61:379-385.
33. Santanam N and Parthasarathy S (2007) Aspirin is a substrate for paraoxonase-like activity: Implications in atherosclerosis. Atherosclerosis 191:272-275.
34. Sarkarati B, Coku-graş AN, and Tezcan EF (1999) Inhibition kinetics of human serum butyrylcholinesterase by Cd2+, Zn2+ and Al3+: Comparison of the effects of metal ions on cholinesterases. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 122:181-190.
35. Satoh T and Hosokawa M (1998) The mammalian carboxylesterases: From molecules to functions. Annu Rev Pharmacol Toxicol 38:257-288.
36. Satoh T and Hosokawa M (2006) Structure, function and regulation of carboxylesterases. Chem Biol Interact 162:195-211.
37. Saxena A, Redman AMG, Jiang X, Lockridge O, and Doctor BP (1997) Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase. Biochemistry 36:14642-14651.
38. Schallreuter KU, Gibbons NC, Elwary SM, Parkin SM, and Wood JM (2007) Calcium-activated butyrylcholinesterase in human skin protects acetylcholinesterase against suicide inhibition by neurotoxic organophosphates. Biochem Biophys Res Commun 355:1069-1074.
39. Tang M, Mukundan M, Yang J, Charpentier N, LeCluyse EL, Black C, Yang D, Shi D, and Yan B (2006) Antiplatelet agents aspirin and clopidogrel are hydrolyzed by distinct carboxylesterases, and clopidogrel is transesterificated in the presence of ethyl alcohol. J Pharmacol Exp Ther 319:1467-1476.
40. Valentino RJ, Lockridge O, Eckerson HW, and La Du BN (1981) Prediction of drug sensitivity in individuals with atypical serum cholinesterase based on in vitro biochemical studies. Biochem Pharmacol 30:1643-1649.
41. Vane JR and Botting RM (2003) The mechanism of action of aspirin. Thromb Res 110:255-258.
42. Williams FM, Mutch EM, Nicholson E, Wynne H, Wright P, Lambert D, and Rawlins MD (1989) Human liver and plasma aspirin esterase. J Pharm Pharmacol 41:407-409.
43. Yang F, Bian C, Zhu L, Zhao G, Huang Z, and Huang M (2007) Effect of human serum albumin on drug metabolism: Structural evidence of esterase activity of human serum albumin. J Struct Biol 157:348-355.
44. Yoshigae Y, Imai T, Taketani M, and Otagiri M (1999) Characterization of esterases involved in the stereoselective hydrolysis of ester-type prodrugs of propranolol in rat liver and plasma. Chirality 11:10-13.